Your browser doesn't support javascript.
loading
Eficacia de Tadalafilo 5 mg en el tratamiento de los síntomas del tracto urinario inferior en pacientes tras fallo de los alfabloqueantes / The efficacy of Tadalafil 5 mg in the treatment of lower urinary tract symptoms in patients where alpha blocker treatments have failed in terms of lower urinary tract symptoms
Atan, Alin; Polat, Fazli; Yesil, Süleyman; Ünsal, Ali; Cem Bulut, Ender; Tokuçoğlu, Haluk; Doğan, Ahmet Emin.
Afiliação
  • Atan, Alin; Gazi University. School of Medicine. Department of Urology. Ankara. Tukey
  • Polat, Fazli; Gazi University. School of Medicine. Department of Urology. Ankara. Tukey
  • Yesil, Süleyman; Gazi University. School of Medicine. Department of Urology. Ankara. Tukey
  • Ünsal, Ali; Gazi University. School of Medicine. Department of Urology. Ankara. Tukey
  • Cem Bulut, Ender; Gazi University. School of Medicine. Department of Urology. Ankara. Tukey
  • Tokuçoğlu, Haluk; Gazi University. School of Medicine. Department of Urology. Ankara. Tukey
  • Doğan, Ahmet Emin; Gazi University. School of Medicine. Department of Urology. Ankara. Tukey
Arch. esp. urol. (Ed. impr.) ; 72(7): 670-675, sept. 2019. tab
Article em Es | IBECS | ID: ibc-187853
Biblioteca responsável: ES1.1
Localização: BNCS
RESUMEN
Objetivos: Investigar la eficacia de tadalafilo 5 mg en pacientes con síntomas del tracto urinario inferior (STUI) tras fallo de los alfabloqueantes. Pacientes y métodos: Treinta y tres pacientes fueron incluidos. Se obtuvo consentimiento informado en todos los casos tras explicarles la eficacia del tadalafilo 5 mg en el tratamiento de los STUI. Antes de iniciar el tratamiento se descartaron cáncer de próstata e infección urinaria. Se evaluaron los valores de los cuestionarios IPSS, IIEF-5 y el Q max antes del tratamiento y al mes del tratamiento. Las diferencias entre los grupos se evaluaron utilizando el método de Wilcoxon. Resultados: Después de un mes con tadalafilo 5 mg, el IPSS disminuyó, y el IIEF-5 y el Q max aumentaron. Las diferencias fueron estadísticamente significativas. Conclusiones: Se ha visto que el tadalafilo 5 mg una vez al día es eficaz en el tratamiento de los STUI/HBP en pacientes con fallo previo del tratamiento con alfabloqueantes
ABSTRACT
Objectives: To investigate the efficacy of tadalafil 5mg in patients with lower urinary tract symptoms who failed alpha blocker treatment. Patients and mehods: Twenty-three patients were included. Patient consent was obtained after explaining the efficacy of tadalafil 5mg in lower urinary tract symptoms. Before initiating tadalafil 5mg treatment, prostate cancer and urinary tract infection in the patients were eliminated. IPSS, IIEF-5 and Qmax values were assessed before and one month after tadalafil 5mg treatment. Difference between two assessments was evaluated by the Wilcoxon method. RESULTS: After 1 month of Tadalafil 5mg treatment, IPSS decreased and IIEF-5 and Qmax increased. The difference between two assessments were statistically significant. Conclusion: Tadalafil 5mg once daily in the treatment of BPH/LUTS is found to be successful in patients who failed previous alpha blocker treatment
Assuntos
Buscar no Google
Coleções: 06-national / ES Base de dados: IBECS Assunto principal: Hiperplasia Prostática / Inibidores da Fosfodiesterase 5 / Sintomas do Trato Urinário Inferior / Tadalafila / Disfunção Erétil Limite: Aged / Humans / Male Idioma: Es Revista: Arch. esp. urol. (Ed. impr.) Ano de publicação: 2019 Tipo de documento: Article
Buscar no Google
Coleções: 06-national / ES Base de dados: IBECS Assunto principal: Hiperplasia Prostática / Inibidores da Fosfodiesterase 5 / Sintomas do Trato Urinário Inferior / Tadalafila / Disfunção Erétil Limite: Aged / Humans / Male Idioma: Es Revista: Arch. esp. urol. (Ed. impr.) Ano de publicação: 2019 Tipo de documento: Article